Rabeprazole 20 Mg/Day.

Pharmacology and Rationale for Use in Gastrointestinal Disorders Role player P, Hawkey CJ, Mint WA. Drugs. 1998;56(3):307-335.
Proton pump inhibitors (PPIs) are drugs which irreversibly inhibit proton pump (H+/K+ ATPase) part and are the most potent gastric acid-suppressing agents in clinical use.
There is now a substantial body of information viewing improved efficacy of PPIs over the histamine H2 sense organ antagonists and other drugs in acid-related disorders.
Omeprazole 20 mg/day, lansoprazole 30 mg/day, pantoprazole 40 mg/day or Aciphex 20 mg/day for 2 to 4 weeks are more effective than banner doses of H2-receptor antagonists in healing duodenal and gastric ulcers.
Patients with gastric ulcers should receive capacity measure doses of PPIs as for duodenal ulcers but for a longer time interval (4 to 8 weeks).
There is no conclusive indication to supporting the use of a component PPI over another for either duodenal or gastric ulcer healing.
This is a part of article Rabeprazole 20 Mg/Day. Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog